Application of multifunctional targeting epirubicin liposomes in the treatment of non-small-cell lung cancer

Código QR

Application of multifunctional targeting epirubicin liposomes in the treatment of non-small-cell lung cancer

Xiao-li Song,1 Rui-jun Ju,2 Yao Xiao,1 Xin Wang,1 Shuang Liu,1 Min Fu,1 Jing-jing Liu,1 Li-yan Gu,1 Xue-tao Li,1 Lan Cheng1 1School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, 2Department of Pharmaceutical Engineering, Beijing Institute of Petrochemical Technology, Bei...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Song X, Ju R, Xiao Y, Wang X, Liu S, Fu M, Liu J, Gu L, Li X, Cheng L
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	octreotide honokiol epirubicin vasculogenic mimicry tumor metastasis non-small cell lung cancer Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/04ad35214d4e45efb3e8879005f57642
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Application of Multifunctional Targeting Epirubicin Liposomes in the Treatment of Non-Small-Cell Lung Cancer [Corrigendum]
por: Song X, et al.
Publicado: (2021)

Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma
por: Ju RJ, et al.
Publicado: (2016)

Marine Bromophenol Bis(2,3,6-Tribromo-4,5-Dihydroxybenzyl)ether Inhibits Angiogenesis in Human Umbilical Vein Endothelial Cells and Reduces Vasculogenic Mimicry in Human Lung Cancer A549 Cells
por: Songtao Dong, et al.
Publicado: (2021)

Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer
por: Wang Y, et al.
Publicado: (2019)

Cyr61 from adipose‐derived stem cells promotes colorectal cancer metastasis and vasculogenic mimicry formation via integrin αVβ5
por: Zhenxing Liang, et al.
Publicado: (2021)

Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases
por: Seung-Uon Shin, et al.
Publicado: (2021)

Preparation of honokiol nanoparticles by liquid antisolvent precipitation technique, characterization, pharmacokinetics, and evaluation of inhibitory effect on HepG2 cells
por: Wu W, et al.
Publicado: (2018)

Canstatin represses glioma growth by inhibiting formation of VM-like structures
por: Ma Yuqiang, et al.
Publicado: (2021)

Self-Assembled Dual-Targeted Epirubicin-Hybrid Polydopamine Nanoparticles for Combined Chemo-Photothermal Therapy of Triple-Negative Breast Cancer
por: Li X, et al.
Publicado: (2020)

Cationic PEGylated liposomes incorporating an antimicrobial peptide tilapia hepcidin 2–3: an adjuvant of epirubicin to overcome multidrug resistance in cervical cancer cells
por: Juang V, et al.
Publicado: (2016)

Synergistic Antitumor Efficacy Mediated by Liposomal Co-Delivery of Polymeric Micelles of Vinorelbine and Cisplatin in Non-Small Cell Lung Cancer
por: Wang S, et al.
Publicado: (2021)

Zebrafish xenograft model for studying mechanism and treatment of non-small cell lung cancer brain metastasis
por: Ruo-Yue Fan, et al.
Publicado: (2021)

TRAP1 Shows Clinical Significance in the Early Diagnosis of Small Cell Lung Cancer
por: Li X, et al.
Publicado: (2021)

NFAT as a Biomarker and Therapeutic Target in Non–Small Cell Lung Cancer–Related Brain Metastasis
por: Lu Peng, et al.
Publicado: (2021)

Sensitive and Selective Electrochemical Detection of Epirubicin as Anticancer Drug Based on Nickel Ferrite Decorated with Gold Nanoparticles
por: Mohammad Mehmandoust, et al.
Publicado: (2021)

Hiperinsulinismo neonatal persistente: Caso clínico y tratamiento médico con octreotide
por: Sacaquirín W,Diego, et al.
Publicado: (2004)

In vitro anticancer activity and oxidative molecular damage by cannabidiol administered alone and in combination with epirubicin
por: Margarita Zhelyazkova, et al.
Publicado: (2021)

The Role of Whole Exome Sequencing in Distinguishing Primary and Secondary Lung Cancers
por: Vokes NI, et al.
Publicado: (2021)

Tumor Microenvironmental Responsive Liposomes Simultaneously Encapsulating Biological and Chemotherapeutic Drugs for Enhancing Antitumor Efficacy of NSCLC
por: Kong L, et al.
Publicado: (2020)

PPy@Fe3O4 Nanoparticles Inhibit Tumor Growth and Metastasis Through Chemodynamic and Photothermal Therapy in Non-small Cell Lung Cancer
por: Danruo Fang, et al.
Publicado: (2021)

<i>POLRMT</i> as a Novel Susceptibility Gene for Cardiotoxicity in Epirubicin Treatment of Breast Cancer Patients
por: Alejandro Velasco-Ruiz, et al.
Publicado: (2021)

Premalignant Changes in the Bronchial Epithelium Are Prognostic Factors of Distant Metastasis in Non-Small Cell Lung Cancer Patients
por: Olga V. Pankova, et al.
Publicado: (2021)

Anti-PD1 Therapy Plus Whole-Brain Radiation Therapy May Prolong PFS in Selected Non–Small Cell Lung Cancer Patients with Brain Metastases: A Retrospective Study
por: Khan M, et al.
Publicado: (2021)

Exosomal miR-136-5p Derived from Anlotinib-Resistant NSCLC Cells Confers Anlotinib Resistance in Non-Small Cell Lung Cancer Through Targeting PPP2R2A
por: Gu G, et al.
Publicado: (2021)

Honokiol alleviates LPS-induced acute lung injury by inhibiting NLRP3 inflammasome-mediated pyroptosis via Nrf2 activation in vitro and in vivo
por: Yuhan Liu, et al.
Publicado: (2021)

Immunotherapy in patients with non-small cell lung cancer with ECOG PS 2
por: Damian Mojsak, et al.
Publicado: (2021)

Systematic review of sequencing of ALK inhibitors in ALK-positive non-small-cell lung cancer
por: Barrows SM, et al.
Publicado: (2019)

Preexposure of MCF-7 breast cancer cell line to dexamethasone alters the cytotoxic effect of paclitaxel but not 5-fluorouracil or epirubicin chemotherapy
por: Buxant F, et al.
Publicado: (2017)

Research on the application of uniportal video-assisted thoracoscopic segmental resection of the lung in elderly patients with non-small cell lung cancer aged over 65 years
por: Hongya Xie, et al.
Publicado: (2021)

ANTIBODIES TO BENZO[A]PYRENE IN SERUM OF PATIENTS WITH NON-SMALL CELL LUNG CANCER
por: E. G. Polenok, et al.
Publicado: (2012)

MTA1 Expression Can Stratify the Risk of Patients with Multifocal Non-Small Cell Lung Cancers ≤3 cm
por: Wang W, et al.
Publicado: (2021)

Intracranial response to a combination of bevacizumab and epirubicin for an adenoid cystic carcinoma of the external auditory canal: A case report and review of the literature
por: Nuria Mederos, et al.
Publicado: (2021)

El juego como proyecto vital de los protagonistas de Háblame de Laura, de Egon Wolff
por: Rueda C,Jorge
Publicado: (2012)

Clinical utility of ramucirumab in non-small-cell lung cancer
por: Uprety D
Publicado: (2019)

Erlotinib eradicates brain metastases from epidermal growth factor receptor mutant non-small cell lung cancer
por: Siavash Jabbari, et al.
Publicado: (2011)

Octreotide long-acting repeatable in the treatment of neuroendocrine tumors: patient selection and perspectives
por: Yau H, et al.
Publicado: (2017)

Predictive Risk Factors for Early Recurrence of Stage pIIIA-N2 Non-Small Cell Lung Cancer
por: Yu Q, et al.
Publicado: (2021)

Small cell transformation of non‐small cell lung cancer under immunotherapy: Case series and literature review
por: Takuma Imakita, et al.
Publicado: (2021)

Biogenesis, functions, and clinical implications of circular RNAs in non-small cell lung cancer
por: Ying Liu, et al.
Publicado: (2022)

Efectos de la infusión aguda de octreotido sobre la función renal en pacientes con cirrosis hepática e hipertensión portal
por: Silva P,Guillermo, et al.
Publicado: (2004)